Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting off Wegovy means working with your prescriber to reduce your dose gradually, monitor your weight, and put a plan in place for what comes next. Most clinical guidance recommends against stopping abruptly, not because semaglutide is physically addictive, but because weight can return quickly once the medicine is withdrawn. These are prescription-only medicines, and how and when you stop is a clinical decision made alongside a qualified prescriber, not a choice to make alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear fairly often is whether someone can just stop taking Wegovy when they feel ready. The honest answer is: you can put the pen down at any time, but doing so without a conversation with your prescriber tends to lead to a harder outcome than it needs to be.
Semaglutide works by reducing appetite signals and slowing how quickly food leaves the stomach. When the medicine clears from your system, those signals return to their baseline. For most people that means hunger increases, portions feel less satisfying, and the weight that was lost can start to come back. The STEP 1 trial, published in the New England Journal of Medicine, followed participants after they stopped semaglutide and found that roughly two-thirds of lost weight was regained within a year of stopping, even in people who continued diet and activity advice.
That is not a reason to stay on it indefinitely if your circumstances have changed. It is a reason to have the conversation first, so you leave with a plan rather than a gap. If you are thinking about stopping because side effects are making things difficult, because you have hit your goal weight, or because you are unsure whether it is still working, all of those are worth raising, and our page covering whether you can get off Wegovy after losing weight goes into each scenario in more detail.
You can find detail on how Wegovy is prescribed and what the treatment journey typically looks like on our Wegovy overview page.
There is a common assumption that the weight loss is permanent once it is gone. It is a hopeful idea, but the biology does not bear it out for most people. Obesity is a long-term condition shaped by hormones, metabolism and genetics, and semaglutide works while it is active in your system. Once you stop, your body's setpoint mechanisms (the processes that push weight back toward where it was) reassert themselves.
The rate of regain varies. Some people maintain a meaningful portion of their loss for a year or longer, particularly those who have made lasting changes to their eating patterns and activity levels, including thinking carefully about what they eat, from everyday choices to questions like whether foods such as steak are suitable while on Wegovy. The evidence on Wegovy outcomes is fairly consistent: lifestyle changes alongside treatment improve the picture, but they rarely prevent all regain on their own once the medicine stops.
This is worth knowing before you stop, not to discourage you but to help you plan. If maintaining a certain weight long-term is the goal, your prescriber can talk through what that looks like, whether that means continuing treatment, stepping down gradually, or a structured stopping plan with close monitoring in the weeks that follow.
NICE's guidance on semaglutide for weight management (published as TA875) sets a maximum of two years for NHS use within specialist services and recommends reviewing whether to continue if less than five percent of body weight has been lost after six months at the maintenance dose. Private prescribing timelines are assessed on an individual basis.
There is no universally mandated tapering schedule for semaglutide the way there is for some other medicines. The titration schedule that takes you up in dose (0.25mg, then 0.5mg, 1.0mg, 1.7mg, up to 2.4mg) is about tolerability and efficacy on the way in. Stepping down on the way out follows the same logic in reverse, but your prescriber decides the right pace based on how you are doing.
For many people, stopping looks like: a review appointment, a conversation about your current dose and your reasons for stopping, and a plan for monitoring weight over the following weeks. If side effects are driving the decision, a dose reduction before a full stop is sometimes the better first move. If you have reached your goal and feel stable, a more direct stop with a follow-up check may suit.
The NHS England guidance on weight management injections recommends that stopping decisions happen within the context of ongoing clinical support, not as a standalone choice. That applies to private patients too. Practical questions about what to eat, how to maintain activity, and what signs of rapid regain to watch for are all worth covering before your last dose, and if you are unsure about the process from the beginning, our guide on how to get Wegovy explains the full prescribing journey in plain terms.
If cost is part of the reason you are thinking about stopping, it is worth knowing that Wegovy pricing varies between providers, and what is included in the price matters as much as the headline figure.
Restarting semaglutide after a break is possible, but it requires a fresh clinical assessment rather than picking up where you left off. This is true whether the gap was a few weeks or several months. Your weight, any changes to your health, and any other medicines you have started in the meantime all need to be considered before a new prescription is issued. You would typically restart at the lowest dose and re-titrate, because the tolerability rationale for the starting dose applies as much on a second course as a first.
If you are weighing whether to restart or explore a different treatment, our weight loss treatment overview covers what is currently licensed in the UK and what each option involves clinically. A prescriber can review your history and help you decide what makes most sense.
When you are ready to speak with a prescriber, start your free consultation and a GPhC-registered Independent Prescriber will review your situation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.